EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease

Claudia-Mariana Handra, Irina-Luciana Gurzu, Marinela Chirila, Isabel Ghita

Frontiers in Bioscience-Landmark · 22.05.2023 · 28 (5)

DOI: 10.31083/j.fbl2805096 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 22.05.2023. Verfasst von Claudia-Mariana Handra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Occupational Medicine Department, "Carol Davila'' University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Silicon Dioxide, Silicosis. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silicosis, an occupational lung disease that can be prevented, is still a significant public health concern in many countries, despite its considerably decreased incidence over the years. The latency period for silicosis ranges from a few years to several decades, depending on the duration and intensity of exposure to silica dust. The complex pathogenic mechanisms of the disease are not fully understood, but it is known to be characterized by inflammation, the formation of silicotic nodules, and progressive and irreversible fibrosis. The aim of this paper was to present the current sources of exposure to silica dust and summarize the updates on risk factors (e.g., socioeconomic status, genetic susceptibility) and sex differences, silico-tuberculosis, prognostic markers including 16-kDa Clara cell secretory protein, antifibrotic treatment, and other therapeutic possibilities with promising results. There are no effective treatment options for silicosis, and prevention remains the primary tool to significantly reduce the risk of disease. There are promising new treatments under investigation including antifibrotic, cellular, and immunomodulatory therapies, but further research is needed to demonstrate the efficacy and safety of these therapies in adequately powered clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideSilicosisFemaleHumansMaleFibrosisInflammationDust

Stichwörter der Autor:innen

antifibrotic treatmentcurrent treatmentfibrosisinflammationsilicosis

Substanzen

Silicon DioxideDust

Autor:innen und Institutionen

  • Occupational Medicine Department, "Carol Davila'' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Occupational Medicine Department, "Gr. T. Popa'' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Faculty of Pharmacy, Titu Maiorescu University, 040441 Bucharest, Romania.
  • Pharmacology and Pharmacotherapy Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Zitieren

APA

Handra, C. M., Gurzu, I. L., Chirila, M., & Ghita, I. (2023). Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease. Frontiers in Bioscience-Landmark, 28(5). https://doi.org/10.31083/j.fbl2805096

Vancouver

Handra CM, Gurzu IL, Chirila M, Ghita I. Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease. Frontiers in Bioscience-Landmark. 2023;28(5). doi:10.31083/j.fbl2805096

BibTeX
@article{Handra2023,
  author = {Handra, Claudia-Mariana and Gurzu, Irina-Luciana and Chirila, Marinela and Ghita, Isabel},
  title = {Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2023},
  volume = {28},
  number = {5},
  doi = {10.31083/j.fbl2805096}
}
Kostenlos starten →